日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Supplementing sialic acid analogs overcomes radiotherapy resistance in triple-negative breast cancer by exacerbating ER stress.

补充唾液酸类似物可通过加剧内质网应激来克服三阴性乳腺癌的放射治疗耐药性

Yang Muwen, Shi Dongni, Lyu Jianbo, Pan Yibing, Lyv Yiyang, Chen Xiangfu, Ouyang Ying, Liu Yajie, Li Yue, Song Libing

Metabolic expression profiling analysis reveals pyruvate-mediated EPHB2 upregulation promotes lymphatic metastasis in head and neck squamous cell carcinomas.

代谢表达谱分析显示,丙酮酸介导的EPHB2上调促进头颈部鳞状细胞癌的淋巴转移

Miao Jingjing, Chen Boyu, Zhang Lu, Lu Zhongming, Wang Rui, Wang Chunyang, Jiang Xingyu, Shen Qi, Li Yue, Shi Dongni, Ouyang Ying, Chen Xiangfu, Deng Xiaowu, Zhang Siyi, Zou Hequn, Chen Shuwei

Direct regulation of FNIP1 and FNIP2 by MEF2 sustains MTORC1 activation and tumor progression in pancreatic cancer

MEF2 对 FNIP1 和 FNIP2 的直接调控维持了胰腺癌中 MTORC1 的激活和肿瘤进展。

Li Xia ,Tiejian Nie ,Fangfang Lu ,Lu Huang ,Xiaolong Shi ,Dongni Ren ,Jianjun Lu ,Xiaobin Li ,Tuo Xu ,Bozhou Cui ,Qing Wang ,Guodong Gao ,Qian Yang

Evaluation of compliance of CONSORT-CHM formula 2017 in randomized controlled trials of Chinese herbal medicine formulas: protocol of a five-year review

中药方剂随机对照试验中CONSORT-CHM 2017方案依从性评价:五年回顾方案

Wang, Juan; Cheng, Chung Wah; Jiao, Yalin; Shi, Dongni; Wang, Yaochen; Li, Han; Wang, Nana; Wang, Xihong; Li, Yuqin; Liang, Feng; Luo, Shufeng; Han, Fei; Li, Ji; Wang, Ping; Lyu, Aiping; Bian, Zhaoxiang; Zhang, Xuan

Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer

SALL2的表观遗传沉默赋予乳腺癌细胞他莫昔芬耐药性

Ye, Liping; Lin, Chuyong; Wang, Xi; Li, Qiji; Li, Yue; Wang, Meng; Zhao, Zekun; Wu, Xianqiu; Shi, Dongni; Xiao, Yunyun; Ren, Liangliang; Jian, Yunting; Yang, Meisongzhu; Ou, Ruizhang; Deng, Guangzheng; Ouyang, Ying; Chen, Xiangfu; Li, Jun; Song, Libing